User contributions
This user is currently blocked. The latest block log entry is provided below for reference:
(Latest | Earliest) View (newer 20) (older 20) (20 | 50 | 100 | 250 | 500).
- 07:29, 7 February 2012 (diff | hist) . . (+35) . . Rizzo Lab Research (→Chemical Sampling Method Development)
- 07:28, 7 February 2012 (diff | hist) . . (+20) . . Rizzo Lab Research (→Method development)
- 07:27, 7 February 2012 (diff | hist) . . (+1,159) . . Rizzo Lab Research (→DOCK development)
- 05:25, 5 February 2012 (diff | hist) . . (-3) . . Rizzo Lab Research (→EGFR and ErbB family)
- 17:34, 3 February 2012 (diff | hist) . . (-8) . . Rizzo Lab Research
- 17:33, 3 February 2012 (diff | hist) . . (+49) . . Rizzo Lab Research
- 17:27, 3 February 2012 (diff | hist) . . (+375) . . Rizzo Lab Research
- 17:16, 3 February 2012 (diff | hist) . . (+283) . . Rizzo Lab Research (→GP41 and viral membrane fusion inhibitor)
- 17:11, 3 February 2012 (diff | hist) . . (+14) . . Rizzo Lab Research (→GP41 and viral membrane fusion inhibitor)
- 17:11, 3 February 2012 (diff | hist) . . (+462) . . Rizzo Lab Research
- 17:01, 3 February 2012 (diff | hist) . . (+12) . . Rizzo Lab Research (→EGFR and ErbB family)
- 17:01, 3 February 2012 (diff | hist) . . (+41) . . Rizzo Lab Research (→EGFR and ErbB family)
- 16:57, 3 February 2012 (diff | hist) . . (+23) . . Rizzo Lab Research (→DOCK development)
- 16:54, 3 February 2012 (diff | hist) . . (+1) . . Rizzo Lab Research (→EGFR and ErbB family)
- 16:03, 3 February 2012 (diff | hist) . . (+2) . . Rizzo Lab Research (→EGFR and ErbB family)
- 15:32, 3 February 2012 (diff | hist) . . (+1) . . Rizzo Lab Research (→EGFR and ErbB family)
- 12:02, 3 February 2012 (diff | hist) . . (0) . . Rizzo Lab Research (→EGFR and ErbB family)
- 12:02, 3 February 2012 (diff | hist) . . (0) . . N File:ErbB Kinases research image1.png (top)
- 11:57, 3 February 2012 (diff | hist) . . (-13) . . Rizzo Lab Research (→EGFR and ErbB family)
- 11:53, 3 February 2012 (diff | hist) . . (+6) . . Rizzo Lab Research (→Cancer)
(Latest | Earliest) View (newer 20) (older 20) (20 | 50 | 100 | 250 | 500).
